Literature DB >> 4473426

Serological reactions of Mycoplasma hominis: differences among mycoplasmacidal, metabolic inhibition, and growth agglutination tests.

J S Lin, E H Kass.   

Abstract

Seven strains of Mycoplasma hominis from human genital tracts were selected to produce antisera. The complement-dependent mycoplasmacidal (MC) activity and two complement-independent activities, metabolic inhibition (MI) and agglutination during growth (GA), of these sera were compared. The GA and MI tests were equivalent in titer and generally not affected by concentration of antigen; they revealed specific cross-reacting patterns among the seven strains. There was little if any cross-reactivity with antisera to other human mycoplasmas or to Mycoplasma arthritidis. Control sera from unimmunized rabbits and sera against concentrated uninoculated culture media were also nonreactive. On the other hand, the sensitivity and specificity of the MC test were affected by the concentration of antigen: at about 10(2) color-changing units (CCU) of antigen, all strains were equivalently cross-reactive against the seven antisera, but at 10(2) to 10(4) CCU the individual strain specificity appeared, whereas at about 10(5) CCU little or no antibody was detectable by MC. The MC tests with the lowest concentrations of antigen gave the highest titers of antibody, but at such low concentrations of antigen there was not only loss of individual strain specificity but also some cross-reactivity against other human mycoplasmas, M. arthritidis, or control rabbit sera. Studies with paired human sera also indicate that the MC test with small amounts of antigen is more sensitive than GA-MI.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4473426      PMCID: PMC422987          DOI: 10.1128/iai.10.3.535-540.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  SIGNIFICANCE OF ANTIBODY TO MYCOPLASMA HOMINIS TYPE 1 AS MEASURED BY INDIRECT HEMAGGLUTINATION.

Authors:  D TAYLOR-ROBINSON; W M LUDWIG; R H PURCELL; M A MUFSON; R M CHANOCK
Journal:  Proc Soc Exp Biol Med       Date:  1965-04

2.  Serologic typing of human genital T-mycoplasmas by a complement-dependent mycoplasmacidal test.

Authors:  J S Lin; M I Kendrick; E H Kass
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  Immune inactivation of T-strain mycoplasmas.

Authors:  J S Lin; E H Kass
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

4.  Birth weight and genital mycoplasmas in pregnancy.

Authors:  P Braun; Y H Lee; J O Klein; S M Marcy; T A Klein; D Charles; P Levy; E H Kass
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

5.  Antigenic differences within the species Mycoplasma hominis.

Authors:  M R Hollingdale; R M Lemcke
Journal:  J Hyg (Lond)       Date:  1970-09
  5 in total
  8 in total

1.  Selection of Mycoplasma hominis PG21 deletion mutants by cultivation in the presence of monoclonal antibody 552.

Authors:  L T Jensen; S Ladefoged; S Birkelund; G Christiansen
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae antibodies.

Authors:  F Busolo; E Tonin; L Conventi
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

3.  Physical and genetic mapping of the genomes of five Mycoplasma hominis strains by pulsed-field gel electrophoresis.

Authors:  S A Ladefoged; G Christiansen
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

4.  Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain.

Authors:  L D Olson; S W Shane; A A Karpas; T M Cunningham; P S Probst; M F Barile
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

5.  Evaluation of intraspecies genetic variation within the 16S rRNA gene of Mycoplasma hominis and detection by polymerase chain reaction.

Authors:  A Blanchard; A Yáñez; K Dybvig; H L Watson; G Griffiths; G H Cassell
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

6.  Fourteen serotypes of ureaplasma urealyticum (T-mycoplasmas) demonstrated by the complement-dependent mycoplasmacidal test.

Authors:  J S Lin; E H Kass
Journal:  Infection       Date:  1980       Impact factor: 3.553

7.  Successive synovial Mycoplasma hominis isolates exhibit apparent antigenic variation.

Authors:  L D Olson; C A Renshaw; S W Shane; M F Barile
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Development of real-time PCR for detection of Mycoplasma hominis.

Authors:  Agata Baczynska; Helle F Svenstrup; Jens Fedder; Svend Birkelund; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2004-09-06       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.